# A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis

> **NCT00236028** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 607 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Infliximab

## Key facts

- **NCT ID:** NCT00236028
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 607 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00236028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00236028, "A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00236028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*